PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18241695-3	2008	The aim of this study was to identify and compare the cellular sources, timing and intensity of MMP-9 induction by zymosan in the murine peritoneal cavity.	Zymosan	115-122	matrix metallopeptidase 9	Mus musculus	96-101	
15259001-14	2004	Staining for MMP-9 could be detected in liver, lung, and spleen tissues of zymosan-treated mice.	Zymosan	75-82	matrix metallopeptidase 9	Mus musculus	13-18	
19175797-2	2009	Recently, we reported that a genetic lack of MMP-9 impairs neutrophil infiltration during early zymosan-induced peritonitis but at later stages (> 24 hr) neutrophils persist in the peritoneal cavity.	Zymosan	96-103	matrix metallopeptidase 9	Mus musculus	45-50	
19175797-8	2009	Similarly, weaker apoptosis of MMP-9(-/-) bone marrow neutrophils treated in vitro with zymosan was reversed by COX-1 inhibition.	Zymosan	88-95	matrix metallopeptidase 9	Mus musculus	31-36	
16530081-4	2006	The aim of the present study was to evaluate the role of MMP-9 in the cell influx during zymosan-induced experimental peritonitis.	Zymosan	89-96	matrix metallopeptidase 9	Mus musculus	57-62	
16530081-5	2006	In zymosan-treated Balb/c mice MMP-9 and its natural inhibitor (tissue inhibitor of metalloproteinase 1 - TIMP-1) were present in the peritoneal fluid and plasma at the time of peritoneal neutrophil (polymorphonuclear leukocyte - PMN) infiltration and persisted there until the time of monocytes/macrophages influx.	Zymosan	3-10	matrix metallopeptidase 9	Mus musculus	31-36	
10340950-8	1999	PMN from gelatinase B-/- mice migrated through Matrigel in response to zymosan-activated serum with the same efficiency as did PMN from gelatinase B+/+ mice.	Zymosan	71-78	matrix metallopeptidase 9	Mus musculus	9-21	
18241695-4	2008	We detected MMP-9 mRNA in unstimulated peritoneal leukocytes and its levels increased after zymosan administration.	Zymosan	92-99	matrix metallopeptidase 9	Mus musculus	12-17	
17826846-2	2007	During the course of zymosan peritonitis MMP-9 is produced in a biphasic-manner as its presence is detectable as early as 30 min post zymosan and then between 2 and 8 h of inflammation.	Zymosan	21-28	matrix metallopeptidase 9	Mus musculus	41-46